ARTICLE | Company News
Abbott, Celera cancer deal
July 7, 2004 7:00 AM UTC
Abbott (ABT) and Celera Genomics (CRA) partnered to develop and commercialize antibodies and small molecules to treat cancer. Under the deal, ABT will screen a number of solid tumor cell-surface antig...